Prediction and diagnosis of leukemia using classification algorithms

Daqqa, Khaled A. S. Abu; Maghari, Ashraf Y. A.; Sarraj, Wael F. M. Al

doi:10.1109/icitech.2017.8079919

Cited by 24 publications

(25 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study authors originated from a variety of countries, including the United States (n=5), countries in the Middle East (n=5), Europe (n=5), and Asia (n=3), with some studies involving multiple countries. The AI techniques were most commonly developed to identify colorectal cancer (n=7) [ 34 , 41 , 42 , 48 , 49 , 52 , 53 ], although they also addressed lung cancer (n=3) [ 39 , 44 , 45 ], hematological cancers (n=2) [ 43 , 51 ], pancreatic cancer (n=1) [ 40 ], prostate cancer (n=1) [ 46 ], and multiple cancers (n=2) [ 47 , 50 ].…”

Section: Resultsmentioning

confidence: 99%

Artificial Intelligence Techniques That May Be Applied to Primary Care Data to Facilitate Earlier Diagnosis of Cancer: Systematic Review

Jones¹,

Calanzani²,

Saji³

et al. 2021

J Med Internet Res

View full text Add to dashboard Cite

Background More than 17 million people worldwide, including 360,000 people in the United Kingdom, were diagnosed with cancer in 2018. Cancer prognosis and disease burden are highly dependent on the disease stage at diagnosis. Most people diagnosed with cancer first present in primary care settings, where improved assessment of the (often vague) presenting symptoms of cancer could lead to earlier detection and improved outcomes for patients. There is accumulating evidence that artificial intelligence (AI) can assist clinicians in making better clinical decisions in some areas of health care. Objective This study aimed to systematically review AI techniques that may facilitate earlier diagnosis of cancer and could be applied to primary care electronic health record (EHR) data. The quality of the evidence, the phase of development the AI techniques have reached, the gaps that exist in the evidence, and the potential for use in primary care were evaluated. Methods We searched MEDLINE, Embase, SCOPUS, and Web of Science databases from January 01, 2000, to June 11, 2019, and included all studies providing evidence for the accuracy or effectiveness of applying AI techniques for the early detection of cancer, which may be applicable to primary care EHRs. We included all study designs in all settings and languages. These searches were extended through a scoping review of AI-based commercial technologies. The main outcomes assessed were measures of diagnostic accuracy for cancer. Results We identified 10,456 studies; 16 studies met the inclusion criteria, representing the data of 3,862,910 patients. A total of 13 studies described the initial development and testing of AI algorithms, and 3 studies described the validation of an AI algorithm in independent data sets. One study was based on prospectively collected data; only 3 studies were based on primary care data. We found no data on implementation barriers or cost-effectiveness. Risk of bias assessment highlighted a wide range of study quality. The additional scoping review of commercial AI technologies identified 21 technologies, only 1 meeting our inclusion criteria. Meta-analysis was not undertaken because of the heterogeneity of AI modalities, data set characteristics, and outcome measures. Conclusions AI techniques have been applied to EHR-type data to facilitate early diagnosis of cancer, but their use in primary care settings is still at an early stage of maturity. Further evidence is needed on their performance using primary care data, implementation barriers, and cost-effectiveness before widespread adoption into routine primary care clinical practice can be recommended.

show abstract

Section: Resultsmentioning

confidence: 99%

Artificial Intelligence Techniques That May Be Applied to Primary Care Data to Facilitate Earlier Diagnosis of Cancer: Systematic Review

Jones¹,

Calanzani²,

Saji³

et al. 2021

J Med Internet Res

View full text Add to dashboard Cite

show abstract

“…Tables 1 and 2 show the main study characteristics for the 16 included studies, including the modality of AI used. Supplementary information on the variables included in the AI techniques is available in Multimedia Appendix 4 [34,[39][40][41][42][43][44][45][46][47][48][49][50][51][52][53]. We categorized the variables included into the following categories: demographics, symptoms, comorbidities, lifestyle history, examination findings, blood results, and other.…”

Section: Resultsmentioning

confidence: 99%

“…We categorized the variables included into the following categories: demographics, symptoms, comorbidities, lifestyle history, examination findings, blood results, and other. Most studies (n=13) described the initial development and testing of an AI technique [39][40][41][42][43][44][45][46][47][48][49][50][51]. Three studies validated the AI technique developed by Kinar et al [48] in independent data sets from 3 different countries (Israel, United States, and United Kingdom) [34,52,53].…”

Section: Resultsmentioning

confidence: 99%

“…The study authors originated from a variety of countries, including the United States (n=5), countries in the Middle East (n=5), Europe (n=5), and Asia (n=3), with some studies involving multiple countries. The AI techniques were most commonly developed to identify colorectal cancer (n=7) [34,41,42,48,49,52,53], although they also addressed lung cancer (n=3) [39,44,45], hematological cancers (n=2) [43,51], pancreatic cancer (n=1) [40], prostate cancer (n=1) [46], and multiple cancers (n=2) [47,50].…”

Section: Resultsmentioning

confidence: 99%

“…The clinical control group was unclear in 2 studies [40,45]. Many studies used multiple AI techniques and then compared them with each other (n=8) [40,42,43,[45][46][47]49,50]. Some studies used non-AI techniques, such as logistic regression and screening tests, as comparators for the performance of the AI technique that was being developed [40,41,45,46,[48][49][50][51].…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Artificial Intelligence Techniques That May Be Applied to Primary Care Data to Facilitate Earlier Diagnosis of Cancer: Systematic Review (Preprint)

Jones¹,

Calanzani²,

Saji³

et al. 2020

Preprint

View full text Add to dashboard Cite

BACKGROUND More than 17 million people worldwide, including 360,000 people in the UK, were diagnosed with cancer in 2018. Cancer prognosis and disease burden is highly dependent on disease stage at diagnosis. Most people diagnosed with cancer first present in primary care settings, where improved assessment of the (often vague) presenting symptoms of cancer could lead to earlier detection, and improved outcomes for patients. There is accumulating evidence that artificial intelligence (AI) can assist clinicians in making better clinical decisions in some areas of healthcare. OBJECTIVE We aimed to systematically review AI technologies based on electronic health record (EHR) data that may facilitate the earlier diagnosis of cancer in primary care settings. We evaluated the quality of the evidence, the phase of development the AI technologies have reached, the gaps that exist in the evidence, and the potential for use in primary care. METHODS We searched Medline, Embase, SCOPUS, and Web of Science databases from 1st January 2000 to 11th June 2019 (PROSPERO ID CRD42020176674), and included all studies providing evidence for accuracy or effectiveness of applying AI technologies to early detection of cancer using electronic health records. We included all study designs, in all settings and all languages. We extended these searches through a scoping review of commercial AI technologies. The main outcomes assessed were measures of diagnostic accuracy for cancer. RESULTS We identified 10,456 studies: 16 met the inclusion criteria, representing the data of 3,862,910 patients. 13 studies described the initial development and testing of AI algorithms and three studies described the validation of an AI technology in independent datasets. One study was based on prospectively collected data; only three studies were based on primary care data. We found no data on implementation barriers or cost-effectiveness. Risk-of-bias assessment highlighted a wide range in study quality. The additional scoping review of commercial AI tools identified 21 technologies, only one meeting our inclusion criteria. Meta-analysis was not undertaken due to heterogeneity of AI modalities, dataset characteristics and outcome measures. CONCLUSIONS Applying AI technologies to electronic health records for early detection of cancer in primary care is at an early stage of maturity. Further evidence is needed on performance using primary care data, implementation barriers and cost-effectiveness before widespread adoption into routine primary care clinical practice can be recommended. This study was supported by funding from the NIHR Cancer Policy Research Programme and Cancer Research UK.

show abstract

Role of Machine Learning in Detection and Classification of Leukemia: A Comparative Analysis

Garg,

Patel

et al. 2023

GANs for Data Augmentation in Healthcare

View full text Add to dashboard Cite

Prediction and diagnosis of leukemia using classification algorithms

Cited by 24 publications

References 10 publications

Artificial Intelligence Techniques That May Be Applied to Primary Care Data to Facilitate Earlier Diagnosis of Cancer: Systematic Review

Artificial Intelligence Techniques That May Be Applied to Primary Care Data to Facilitate Earlier Diagnosis of Cancer: Systematic Review

Artificial Intelligence Techniques That May Be Applied to Primary Care Data to Facilitate Earlier Diagnosis of Cancer: Systematic Review (Preprint)

Role of Machine Learning in Detection and Classification of Leukemia: A Comparative Analysis

Contact Info

Product

Resources

About